Signifier Medical Technologies, a medical technology company, has named Philip Hess as its new chief operating officer, it was reported on Tuesday.
In the new role, Hess will be responsible for increasing Signifier Medical Technologies' US infrastructure in preparation for the commercialisation of the company's products. He will also head the establishment of new research and development function to identify and leverage innovative science to create new product opportunities for the company.
Hess has served as president & CEO of Bose Corporation, where he worked for 24 years across multiple leadership and operational roles.
POLYTECH Health & Aesthetics announces Poland expansion
Santhera Pharmaceuticals signs Gulf region distribution agreement with Uniphar
Novo Nordisk expands legal action over compounded 'semaglutide'
Neuraxpharm launches Neuraxpharm Australia
OncoZenge selects Meribel Pharma as CDMO for Phase 3 BupiZenge project
Fridays nominated for World Out of Home awards for weight loss campaign
Physiomics expands into biometrics with two contract wins and new division head
DELFI Diagnostics CTO receives 2025 Most Influential Women in Bay Area Business recognition
Clario acquires imaging provider NeuroRx
Healthcare Holding Schweiz AG acquires Effectum CH-Rep AG to expand services
iOncologi acquires TargImmune Therapeutics
Zydus enters exclusive talks to acquire majority stake in Amplitude Surgical
Adcendo's ADCE-T02 Phase I study IND application receives US FDA approval